by Lupus Foundation, Ohio | Sep 10, 2026 | Lupus Foundation of America, News & Events
A new investigative therapy, afimetoran, for adults with systemic lupus erythematosus (SLE) met its primary endpoint in a Phase 2 global, double-blind, randomized, dose-ranging, placebo-controlled trial (NCT04895696), showing a clear, statistically significant, and...
by | Sep 4, 2026 | Lupus Foundation of America
Chronic pain is a daily challenge for many people living with lupus, but the mental health impacts of pain are often overlooked. This post was originally published on this...
by Lupus Foundation, Ohio | Sep 4, 2026 | Lupus Foundation of America, News & Events
A new study comparing perspectives about disease flares in people with systemic autoimmune rheumatic diseases (SARD), like systemic lupus erythematosus (SLE), and clinicians found differences in how each recognizes a flare, especially in how quickly they begin and how...
by | Sep 3, 2026 | Lupus Foundation of America
This November, nine Racing to End Lupus team members will be taking on 26.2 miles across the Big Apple in the TCS New York City Marathon. This post was originally published on this...
by | Sep 3, 2026 | Lupus Foundation of America
Beginning in September, the Lupus Foundation of America’s 2026 Walk to End Lupus Now events will unite people with lupus, their families, and supporters in communities nationwide. This post was originally published on this...
by Lupus Foundation, Ohio | Sep 3, 2026 | Lupus Foundation of America, News & Events
A new study found two distinct biological patterns of lupus nephritis (LN), offering researchers a closer look at why kidney involvement may vary from person to person. This post was originally published on this...
